Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3276360
Max Phase: Preclinical
Molecular Formula: C19H21Cl2NO7
Molecular Weight: 356.25
Molecule Type: Small molecule
Associated Items:
ID: ALA3276360
Max Phase: Preclinical
Molecular Formula: C19H21Cl2NO7
Molecular Weight: 356.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)C(=O)O.OC(CNCCOc1c(Cl)cccc1Cl)COc1ccccc1
Standard InChI: InChI=1S/C17H19Cl2NO3.C2H2O4/c18-15-7-4-8-16(19)17(15)22-10-9-20-11-13(21)12-23-14-5-2-1-3-6-14;3-1(4)2(5)6/h1-8,13,20-21H,9-12H2;(H,3,4)(H,5,6)
Standard InChI Key: AYRLUAYLPNNZTL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 356.25 | Molecular Weight (Monoisotopic): 355.0742 | AlogP: 3.40 | #Rotatable Bonds: 9 |
Polar Surface Area: 50.72 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.70 | CX LogP: 3.67 | CX LogD: 2.36 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.68 | Np Likeness Score: -0.83 |
1. Smith LH, Tucker H.. (1977) beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols., 20 (12): [PMID:22750] [10.1021/jm00222a022] |
Source(1):